SG Americas Securities’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

SG Americas Securities’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-199,178	Closed	-$4.17M	–	3723
2016 Q3	$4.17M	Buy	+199,178	New	+$2.29M	0.04%	404

SG Americas Securities's VTAE Position: Q4 2016 in Review

SG Americas Securities sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 199,178 shares — an estimated $4.17M sold.

SG Americas Securities first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $4.17M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

SG Americas Securities reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
SG Americas Securities sold 199,178 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $4.17M.
SG Americas Securities first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
SG Americas Securities's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $4.17M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on SG Americas Securities's 13F filing for Q4 2016, filed 8 Feb 2017.